USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabi...
USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα
About this item
Full title
Author / Creator
Zhuang, Ting , Zhang, Shuqing , Liu, Dongyi , Li, Zhongbo , Li, Xin , Li, Jiaoyan , Yang, Penghe , Zhang, Chenmiao , Cui, Jiayao , Fu, Mingxi , Shen, Fangyu , Yuan, Lei , Zhang, Zhao , Su, Peng , Zhu, Jian and Yang, Huijie
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
Breast cancer is the most prevalent cancer in women globally. Over-activated estrogen receptor (ER) α signaling is considered the main factor in luminal breast cancers, which can be effectively managed with selective estrogen receptor modulators (SERMs) like tamoxifen. However, approximately 30-40% of ER + breast cancer cases are recurrent after ta...
Alternative Titles
Full title
USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_768a7bedac244ef4a0d279eea2a13216
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_768a7bedac244ef4a0d279eea2a13216
Other Identifiers
ISSN
1756-9966
E-ISSN
1756-9966
DOI
10.1186/s13046-024-03160-2
